Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9

  1. Barbara Commisso
  2. Lingjun Ding
  3. Karl Varadi
  4. Martin Gorges
  5. David Bayer
  6. Tobias M Boeckers
  7. Albert C Ludolph
  8. Jan Kassubek
  9. Oliver Mueller
  10. Francesco Roselli  Is a corresponding author
  1. University of Ulm, Germany
  2. University Hospital Heidelberg, Germany
  3. University of Kiel, Germany

Abstract

Amyotrophic Lateral Sclerosis (ALS) is characterized by the progressive degeneration of motoneurons in the primary motor cortex (pMO) and in spinal cord. However, the pathogenic process involves multiple subnetworks in the brain and functional MRI studies demonstrate an increase in functional connectivity in areas connected to pMO despite the ongoing neurodegeneration. The extent and the structural basis of the motor subnetwork remodelling in experimentally-tractable models remain unclear. We have developed a new retrograde AAV9 to quantitatively map the projections to pMO in the SOD1(G93A) ALS mouse model. We show an increase in the number of neurons projecting from somatosensory cortex to pMO at presymptomatic stages, followed by an increase in projections from thalamus, auditory cortex and contralateral MO (inputs from 20 other structures remains unchanged) as disease advances. The stage- and structure-dependent remodeling of projection to pMO in ALS may provide insights into the hyperconnectivity observed in ALS patients.

Data availability

All the murine data generated or analysed during this study are included in the manuscript and supporting files. The raw images are deposited on the Dataverse database (https://doi.org/10.7910/DVN/5VNSXE)

Article and author information

Author details

  1. Barbara Commisso

    Department of Neurology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Lingjun Ding

    Department of Neurology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Karl Varadi

    Department of Internal Medicine III, University Hospital Heidelberg, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Martin Gorges

    Department of Neurology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. David Bayer

    Department of Neurology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Tobias M Boeckers

    Department of Anatomy and Cell Biology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Albert C Ludolph

    Department of Neurology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Jan Kassubek

    Department of Neurology, University of Ulm, Ulm, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Oliver Mueller

    Dept. of Internal Medicine III, University of Kiel, Kiel, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Francesco Roselli

    Department of Neurology, University of Ulm, Ulm, Germany
    For correspondence
    francesco.roselli@uni-ulm.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9935-6899

Funding

Baustein program-Ulm University Medical Faculty

  • Francesco Roselli

Deutsche Forschungsgemeinschaft (GRK1789)

  • David Bayer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Moritz Helmstaedter, Max Planck Institute for Brain Research, Germany

Ethics

Animal experimentation: All animal experiments have been approved by the Regierungpraesidium Tubingen under the licence no. 1312. All animals were handled according to the federal regulations on animal experimentations and under the supervision of the local veterinary office. Every effort was made to adhere to the 3R guidelines and to minimize suffering.

Human subjects: All subjects included in the human study provided written informed consent according to institutional guidelines; the consent includes the declaration of the understanding of the study design, the agreement to the participation to the study, to the publication of the results, and to the data protection and anonymization procedures (under the chaptes Einwilligungserklaerung"", ""Probandeninformation"", ""Darstellung der Experimente"", ""Datenschutzerklärung""). The study was approved by the Ethics Committee of Ulm University, Ulm, Germany (reference #19/12) and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Version history

  1. Received: March 23, 2018
  2. Accepted: August 21, 2018
  3. Accepted Manuscript published: August 23, 2018 (version 1)
  4. Version of Record published: September 5, 2018 (version 2)

Copyright

© 2018, Commisso et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,567
    Page views
  • 437
    Downloads
  • 17
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Barbara Commisso
  2. Lingjun Ding
  3. Karl Varadi
  4. Martin Gorges
  5. David Bayer
  6. Tobias M Boeckers
  7. Albert C Ludolph
  8. Jan Kassubek
  9. Oliver Mueller
  10. Francesco Roselli
(2018)
Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9
eLife 7:e36892.
https://doi.org/10.7554/eLife.36892

Share this article

https://doi.org/10.7554/eLife.36892

Further reading

    1. Developmental Biology
    2. Neuroscience
    Tariq Zaman, Daniel Vogt ... Michael R Williams
    Research Article

    The cell-type-specific expression of ligand/receptor and cell-adhesion molecules is a fundamental mechanism through which neurons regulate connectivity. Here, we determine a functional relevance of the long-established mutually exclusive expression of the receptor tyrosine kinase Kit and the trans-membrane protein Kit Ligand by discrete populations of neurons in the mammalian brain. Kit is enriched in molecular layer interneurons (MLIs) of the cerebellar cortex (i.e., stellate and basket cells), while cerebellar Kit Ligand is selectively expressed by a target of their inhibition, Purkinje cells (PCs). By in vivo genetic manipulation spanning embryonic development through adulthood, we demonstrate that PC Kit Ligand and MLI Kit are required for, and capable of driving changes in, the inhibition of PCs. Collectively, these works in mice demonstrate that the Kit Ligand/Kit receptor dyad sustains mammalian central synapse function and suggest a rationale for the affiliation of Kit mutation with neurodevelopmental disorders.

    1. Neuroscience
    Hideo Hagihara, Hirotaka Shoji ... Tsuyoshi Miyakawa
    Research Article

    Increased levels of lactate, an end-product of glycolysis, have been proposed as a potential surrogate marker for metabolic changes during neuronal excitation. These changes in lactate levels can result in decreased brain pH, which has been implicated in patients with various neuropsychiatric disorders. We previously demonstrated that such alterations are commonly observed in five mouse models of schizophrenia, bipolar disorder, and autism, suggesting a shared endophenotype among these disorders rather than mere artifacts due to medications or agonal state. However, there is still limited research on this phenomenon in animal models, leaving its generality across other disease animal models uncertain. Moreover, the association between changes in brain lactate levels and specific behavioral abnormalities remains unclear. To address these gaps, the International Brain pH Project Consortium investigated brain pH and lactate levels in 109 strains/conditions of 2294 animals with genetic and other experimental manipulations relevant to neuropsychiatric disorders. Systematic analysis revealed that decreased brain pH and increased lactate levels were common features observed in multiple models of depression, epilepsy, Alzheimer’s disease, and some additional schizophrenia models. While certain autism models also exhibited decreased pH and increased lactate levels, others showed the opposite pattern, potentially reflecting subpopulations within the autism spectrum. Furthermore, utilizing large-scale behavioral test battery, a multivariate cross-validated prediction analysis demonstrated that poor working memory performance was predominantly associated with increased brain lactate levels. Importantly, this association was confirmed in an independent cohort of animal models. Collectively, these findings suggest that altered brain pH and lactate levels, which could be attributed to dysregulated excitation/inhibition balance, may serve as transdiagnostic endophenotypes of debilitating neuropsychiatric disorders characterized by cognitive impairment, irrespective of their beneficial or detrimental nature.